Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 May 15:11:744.
doi: 10.3389/fphar.2020.00744. eCollection 2020.

A Review of the Effects of Natural Compounds, Medicinal Plants, and Mushrooms on the Gut Microbiota in Colitis and Cancer

Man Kit Cheung  1 , Grace Gar Lee Yue  2   3 , Philip Wai Yan Chiu  1 , Clara Bik San Lau  2   3
Affiliations
Review

A Review of the Effects of Natural Compounds, Medicinal Plants, and Mushrooms on the Gut Microbiota in Colitis and Cancer

Man Kit Cheung et al. Front Pharmacol. .

Abstract

The human gastrointestinal tract harbors a diverse array of microorganisms that play fundamental roles in health and disease. Imbalance in the gut microbiota, namely dysbiosis, can lead to various diseases, including cancer and gastrointestinal tract disorders. Approaches to improve gut dysbiosis, such as dietary intervention, intake of probiotics, and fecal microbiota transplantation are emerging strategies to treat these diseases. Various medicinal botanicals have reported anti-cancer and/or anti-inflammatory properties. Preclinical studies have illustrated that some of these natural products are also capable to modulate the gut microbiota, suggesting their use as possible alternative approach to improve gut dysbiosis and thereby assist diseases treatment. In this review article, we have summarized the current knowledge on the effects of natural compounds, medicinal plants, and mushrooms on the gut microbiota in various cancers and colitis in preclinical animal models. Challenges towards the clinical use of these medicinal botanicals as modulators of the gut microbiota in cancer and colitis treatment are also discussed.

Keywords: cancer; colitis; dysbiosis; herbs; medicinal botanicals; microbiome; microbiota; natural products.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Almasaudi S. B. (2018). Acinetobacter spp. as nosocomial pathogens: Epidemiology and resistance features. Saudi J. Biol. Sci. 25, 586–596. 10.1016/j.sjbs.2016.02.009 - DOI - PMC - PubMed
    1. Anhê F. F., Marette A. (2017). A microbial protein that alleviates metabolic syndrome. Nat. Med. 23, 11–12. 10.1038/nm.4261 - DOI - PubMed
    1. Armstrong H., Bording-Jorgensen M., Dijk S., Wine E. (2018). The complex interplay between chronic inflammation, the microbiome, and cancer: understanding disease progression and what we can do to prevent it. Cancers 10, E83. 10.3390/cancers10030083 - DOI - PMC - PubMed
    1. Arumugam M., Raes J., Pelletier E., Le Paslier D., Yamada T., Mende D. R., et al. (2011). Enterotypes of the human gut microbiome. Nature 473, 174–180. 10.1038/nature09944 - DOI - PMC - PubMed
    1. Asha, Gayathri D. (2012). Synergistic impact of Lactobacillus fermentum, Lactobacillus plantarum and vincristine on 1,2-dimethylhydrazine-induced colorectal carcinogenesis in mice. Exp. Ther. Med. 3, 1049–1054. 10.3892/etm.2012.536 - DOI - PMC - PubMed

LinkOut - more resources